| Title: | A 6 month patient profile of the Connolly Hospital COVID-19@Home Monitoring Service |
|---|---|
| Author(s): | S. Delahunty, S. Nolan, Dr. L. Cormican, C. Feeney, H. Johnston, A. McGowan, L. Brien, M. McGrane, C. Devine C. Browne |
| Institution: | Connolly Hospital Blanchardstown |
| Poster: | Click to view poster |
| Category: | COVID 19 |
| Abstract: | The study aimed to provide a six month insight into the service outcomes and user demographics of the COVID-19 at Home (CO@H) Remote Monitoring Service in Connolly Hospital Blanchardstown. The service was founded to optimise timely discharge, appropriately escalate acute deterioration, minimise patient mortality and enhance acute recovery following COVID-19 infection. Collation and analysis of patient data from both inpatient and CO@H monitoring periods. Utilised a bespoke database and patients logging data four times daily via patientMpower technology. 126 patients were enrolled onto the programme, 123 of which completed the programme with 0% mortality. The patient cohort ranged from 20-88 years with 53.2%:46.8% male:female. 8% of patients (9) developed a PE pre-enrolment on the service. One patient who was re-admitted developed a PE during their re-admission. 8% of patients who completed the CO@H programme required re-admission to hospital. Upon discharge, resting tachycardia (≥100bpm) was found in 16.3% of patients who completed the service (20/123) and 21% required referral to post COVID-19 physiotherapy (26/123). Ethnicity: Irish (63): 50% Asian (15): 11.9% African (10): 7.9% Other European (32): 25.4% Unknown (4): 3.2% In-patient Care: ICU (7): 5.5% Intubation (4): 3.2% NIV, CPAP, BiPAP, Airvo, Hi-flow O_2 (8): 6.3% O2 (82): 65% Antibiotics (110): 87.3% Steroids (102): 81% Anti-coagulation (88): 69.8% Vitamin D (50): 39.7% Diuretics (26): 20.6% Remdesivir (6): 4.8% Tocilizumab (5): 4% Co-morbidities 3+ co-morbidities (23): 18.5% Cardiac history (42): 33.9% Respiratory condition (32): 25.8% Asthma (16): 12.7 HTN (33): 26.2% COPD (5): 4% Increased BMI (16): 12.7% CCF (6): 4.8% High cholesterol (11): 8.7% DM (11): 8.7% T1DM (2): 1.6% T2DM (9): 7.1% CVA (3): 2.4% Cancer (3): 2.4% Ex-smoker (6): 4.8% Discharged on anticoagulation (47): 37.3% Reason for Readmission: Desaturation (6): 4.8% High temperature (4): 3.2% Chest pain (2): 1.6% Gastric issues (1): 0.8% Pneumonia (1): 0.8% Irregular heart rate (1): 0.8% Productive cough (1): 0.8% CO@H is a safe and effective method to monitor patients at home. Patients had their care appropriately escalated in the case of deterioration. Early access to Post COVID-19 physiotherapy services was provided for timely chronic disease management. At monitoring completion, resting tachycardia was evident within this patient group. |
